Canakinumab for the treatment of autoinflammatory recurrent fever syndromes

F. De Benedetti, M. Gattorno, J. Anton, B.-C. Eldad, J. Frenkel, H.M. Hoffman, K.-P. Isabelle, H.J. Lachmann, S. Ozen, A. Simon, A. Zeft, I.C. Penades, M. Moutschen, P. Quartier, O. Kasapcopur, A. Shcherbina, M. Hofer, P.J. Hashkes, J. Van der Hilst, R. HaraB.-R. Segundo, T. Constantin, A. Gul, A. Livneh, P. Brogan, M. Cattalini, L. Obici, K. Lheritier, A. Speziale, G. Junge

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1908-1919
Number of pages12
JournalNew England Journal of Medicine
Volume378
Issue number20
DOIs
Publication statusPublished - 2018

Cite this

De Benedetti, F., Gattorno, M., Anton, J., Eldad, B-C., Frenkel, J., Hoffman, H. M., Isabelle, K-P., Lachmann, H. J., Ozen, S., Simon, A., Zeft, A., Penades, I. C., Moutschen, M., Quartier, P., Kasapcopur, O., Shcherbina, A., Hofer, M., Hashkes, P. J., Van der Hilst, J., ... Junge, G. (2018). Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. New England Journal of Medicine, 378(20), 1908-1919. https://doi.org/10.1056/NEJMoa1706314